IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $863 | +48.8% | 54,391 | +77.0% | 0.05% | +62.1% |
| Q2 2023 | $580 | +29.2% | 30,730 | -73.7% | 0.03% | +45.0% |
| Q1 2023 | $449 | -22.7% | 116,899 | -0.1% | 0.02% | -28.6% |
| Q4 2022 | $581 | -99.9% | 117,000 | -1.5% | 0.03% | +3.7% |
| Q3 2022 | $568,000 | +11260.0% | 118,800 | +17396.3% | 0.03% | – |
| Q4 2021 | $5,000 | -96.9% | 679 | -95.5% | 0.00% | -100.0% |
| Q3 2014 | $159,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |